These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7694915)

  • 1. Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder.
    Coplan JD; Papp LA; Martinez J; Pine D; Rosenblum LA; Cooper T; Liebowitz MR; Gorman JM
    Am J Psychiatry; 1995 Apr; 152(4):619-22. PubMed ID: 7694915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blunted growth hormone responses to growth hormone-releasing factor and to clonidine in panic disorder.
    Tancer ME; Stein MB; Black B; Uhde TW
    Am J Psychiatry; 1993 Feb; 150(2):336-7. PubMed ID: 8422091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
    Gann H; Riemann D; Stoll S; Berger M; Müller WE
    Pharmacopsychiatry; 1995 May; 28(3):80-3. PubMed ID: 7568369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder.
    Coplan JD; Papp LA; Pine D; Martinez J; Cooper T; Rosenblum LA; Klein DF; Gorman JM
    Arch Gen Psychiatry; 1997 Jul; 54(7):643-8. PubMed ID: 9236548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers.
    Uhde TW; Tancer ME; Rubinow DR; Roscow DB; Boulenger JP; Vittone B; Gurguis G; Geraci M; Black B; Post RM
    Neuropsychopharmacology; 1992 Feb; 6(2):101-18. PubMed ID: 1610485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers.
    Tancer ME; Stein MB; Uhde TW
    Biol Psychiatry; 1993 Nov; 34(9):591-5. PubMed ID: 8292687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 2-adrenergic receptor sensitivity in panic disorder: I. GH response to GHRH and clonidine stimulation in panic disorder.
    Brambilla F; Perna G; Garberi A; Nobile P; Bellodi L
    Psychoneuroendocrinology; 1995; 20(1):1-9. PubMed ID: 7838898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncoupling of the noradrenergic-hypothalamic-pituitary-adrenal axis in panic disorder patients.
    Coplan JD; Pine D; Papp L; Martinez J; Cooper T; Rosenblum LA; Gorman JM
    Neuropsychopharmacology; 1995 Aug; 13(1):65-73. PubMed ID: 8526972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four hour growth hormone secretion in patients with panic disorder.
    Abelson JL; Curtis GC; Uhde TW
    Psychoneuroendocrinology; 2005 Jan; 30(1):72-9. PubMed ID: 15358444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder.
    Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
    Biol Psychiatry; 1992 Jul; 32(1):18-25. PubMed ID: 1391293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blunted growth hormone response to peripheral infusion of human growth hormone-releasing factor in patients with panic disorder.
    Rapaport MH; Risch SC; Gillin JC; Golshan S; Janowsky DS
    Am J Psychiatry; 1989 Jan; 146(1):92-5. PubMed ID: 2492166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fluoxetine on dexamethasone-induced growth hormone release in depression: a double-blind, placebo-controlled study.
    Thakore JH; Dinan TG
    Am J Psychiatry; 1995 Apr; 152(4):616-8. PubMed ID: 7694914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
    Charney DS; Woods SW; Krystal JH; Nagy LM; Heninger GR
    Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GH response to intravenous clonidine challenge correlates with history of childhood trauma in personality disorder.
    Lee RJ; Fanning JR; Coccaro EF
    J Psychiatr Res; 2016 May; 76():38-43. PubMed ID: 26874268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.
    Pecknold JC; Luthe L; Iny L; Ramdoyal D
    J Psychiatry Neurosci; 1995 May; 20(3):193-8. PubMed ID: 7786880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation strategies with tricyclic or fluoxetine treatment in seven partially responsive panic disorder patients.
    Tiffon L; Coplan JD; Papp LA; Gorman JM
    J Clin Psychiatry; 1994 Feb; 55(2):66-9. PubMed ID: 8077156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
    Mavissakalian MR; Perel JM
    Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipanic effect of fluoxetine measured by CO2 challenge test.
    Bocola V; Trecco MD; Fabbrini G; Paladini C; Sollecito A; Martucci N
    Biol Psychiatry; 1998 Apr; 43(8):612-5. PubMed ID: 9564447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone response to clonidine in male patients with panic disorder untreated by antidepressants.
    Schittecatte M; Ansseau M; Charles G; Machowski R; Papart P; Pichot W; Wilmotte J
    Psychol Med; 1992 Nov; 22(4):1059-62. PubMed ID: 1488479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pregnancy on panic disorder: a case series.
    Cohen LS; Sichel DA; Dimmock JA; Rosenbaum JF
    J Clin Psychiatry; 1994 Jul; 55(7):284-8. PubMed ID: 7915272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.